Concepedia

Michael Marentette

MM

Statistics

Publications

9

Citations

469

H-Index

9

Active since

2001

Affiliations

Merck Canada Inc. (Canada)(Current)

McGill University

Merck & Co., Inc., Rahway, NJ, USA (United States)

McMaster University

TransCanada (Canada)

Michael Marentette is an author at Merck Canada Inc. (Canada) specializing in clinical pharmacology, medicine, and pharmacotherapy.

Publications per year

2001–2006

9

Publications

9

Antihypertensive persistence and drug class.

Michael Marentette, William C. Gerth, David K. Billings et al. · PubMed · 2002 · 127 citations

, , +14

Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study

Chantal Bourgault, Martin Sénécal, Marc Brisson et al. · Journal of Human Hypertension · 2005 · 115 citations

, , +12

Use of NSAIDs, COX‐2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population

Elham Rahme, Michael Marentette, Sheldon X. Kong et al. · Arthritis Care & Research · 2002 · 61 citations

, , +13

Incremental Cost-Effectiveness Analysis Comparing Rofecoxib with Nonselective NSAIDs in Osteoarthritis

John K. Marshall, James M. Pellissier, Cheryl Attard et al. · PharmacoEconomics · 2001 · 46 citations

, , +14

Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).

Chantal Bourgault, Jean Davignon, George Fodor et al. · PubMed · 2005 · 41 citations

, , +12

1–5 of 9